These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34957784)

  • 21. Evaluation of trimetazidine in angina pectoris by echocardiography and radionuclide angiography: a meta-analysis of randomized, controlled trials.
    Hu B; Li W; Xu T; Chen T; Guo J
    Clin Cardiol; 2011 Jun; 34(6):395-400. PubMed ID: 21538382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
    Sellier P; Broustet JP
    Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure.
    Gao D; Ning N; Niu X; Hao G; Meng Z
    Heart; 2011 Feb; 97(4):278-86. PubMed ID: 21134903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
    Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials.
    Marzilli M; Klein WW
    Coron Artery Dis; 2003 Apr; 14(2):171-9. PubMed ID: 12655281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of Aerobic Exercise on N-terminal Pro-B-type Natriuretic Peptide and Cardiopulmonary Function in Patients With Heart Failure: A Meta-Analysis of Randomised Clinical Trials.
    Santoso A; Maulana R; Alzahra F; Prameswari HS; Ambari AM; Hartopo AB; Arso IA; Radi B
    Heart Lung Circ; 2020 Dec; 29(12):1790-1798. PubMed ID: 32665172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
    Multicentral Collaborative Group on Trimetazidine (Phase IV)
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):793-5. PubMed ID: 16266453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of trimetazidine on heart rate variability in patients with heart failure.
    Gunes Y; Guntekin U; Tuncer M; Sahin M
    Arq Bras Cardiol; 2009 Aug; 93(2):154-8. PubMed ID: 19838493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Trimetazidine on Diabetic Patients with Coronary Heart Diseases: A Meta-Analysis of Randomized, Controlled Trials.
    Lin Y; Wang ZL; Yan M; Zhu FY; Duan Y; Sun ZQ
    Chin Med Sci J; 2020 Sep; 35(3):226-238. PubMed ID: 32972500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure: A Meta-analysis of Randomized Controlled Trials.
    Turagam MK; Garg J; Whang W; Sartori S; Koruth JS; Miller MA; Langan N; Sofi A; Gomes A; Choudry S; Dukkipati SR; Reddy VY
    Ann Intern Med; 2019 Jan; 170(1):41-50. PubMed ID: 30583296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of trimetazidine added to pharmacological treatment on all-cause mortality in patients with systolic heart failure.
    Grajek S; Michalak M
    Cardiology; 2015; 131(1):22-9. PubMed ID: 25832112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical effect of various trimetazidine formulations in chronic coronary syndrome].
    Nagy VL; Herold Z
    Orv Hetil; 2020 Apr; 161(16):611-622. PubMed ID: 32323965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis.
    Danchin N; Marzilli M; Parkhomenko A; Ribeiro JP
    Cardiology; 2011; 120(2):59-72. PubMed ID: 22122948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise-based cardiac rehabilitation in patients with reduced left ventricular ejection fraction: The Cardiac Rehabilitation Outcome Study in Heart Failure (CROS-HF): A systematic review and meta-analysis.
    Bjarnason-Wehrens B; Nebel R; Jensen K; Hackbusch M; Grilli M; Gielen S; Schwaab B; Rauch B;
    Eur J Prev Cardiol; 2020 Jun; 27(9):929-952. PubMed ID: 31177833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy - Six months follow-up result.
    Momen A; Ali M; Karmakar PK; Ali MZ; Haque A; Khan MR; Khalil MI; Hossain MS; Huda RM; Goni MN
    Indian Heart J; 2016; 68(6):809-815. PubMed ID: 27931552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Trimetazidine in Limiting Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Wang C; Chen W; Yu M; Yang P
    Angiology; 2021 Jul; 72(6):511-523. PubMed ID: 33472383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of trimetazidine on left ventricular function in patients with type 2 diabetes and heart failure.
    Thrainsdottir IS; von Bibra H; Malmberg K; Rydén L
    J Cardiovasc Pharmacol; 2004 Jul; 44(1):101-8. PubMed ID: 15175564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of trimetazidine on p-wave duration and dispersion in heart failure patients.
    Gunes Y; Tuncer M; Guntekin U; Akdag S; Gumrukcuoglu HA
    Pacing Clin Electrophysiol; 2009 Feb; 32(2):239-44. PubMed ID: 19170914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.
    Wu L; Luan Y; Li Y; Wang M; He J; Jin C; Zhang W
    BMC Cardiovasc Disord; 2020 Jun; 20(1):273. PubMed ID: 32503494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.